{"pmid":32348233,"title":"Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.","text":["Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.","We report 3 patients with coronavirus disease who had a decline in respiratory status during their hospital course that responded well to intravenous steroids and interleukin-6 receptor antagonist therapy. These patients later showed development of persistent hypoxia with increased levels of d-dimer levels and were given a diagnosis of pulmonary embolisms.","Emerg Infect Dis","Griffin, Daniel O","Jensen, Alexandra","Khan, Mushmoom","Chin, Jessica","Chin, Kelly","Saad, Jennifer","Parnell, Ryan","Awwad, Christopher","Patel, Darshan","32348233"],"abstract":["We report 3 patients with coronavirus disease who had a decline in respiratory status during their hospital course that responded well to intravenous steroids and interleukin-6 receptor antagonist therapy. These patients later showed development of persistent hypoxia with increased levels of d-dimer levels and were given a diagnosis of pulmonary embolisms."],"journal":"Emerg Infect Dis","authors":["Griffin, Daniel O","Jensen, Alexandra","Khan, Mushmoom","Chin, Jessica","Chin, Kelly","Saad, Jennifer","Parnell, Ryan","Awwad, Christopher","Patel, Darshan"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348233","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3201/eid2608.201477","keywords":["covid-19","sars-cov-2","coronavirus disease","d-dimer","deep vein thrombosis","hypercoagulability","prophylaxis","pulmonary embolism","respiratory infections","sequelae","severe acute respiratory syndrome coronavirus 2","thromboembolic","viruses"],"e_drugs":["Steroids"],"topics":["Case Report"],"weight":1,"_version_":1666138495448514560,"score":9.490897,"similar":[{"pmid":32405161,"pmcid":"PMC7219417","title":"D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","text":["D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","Objective: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. Methods: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. Results: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. Conclusion: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE.","Respir Med","Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Capa, Jorge Abad","Rosell, Antoni","32405161"],"abstract":["Objective: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. Methods: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. Results: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. Conclusion: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE."],"journal":"Respir Med","authors":["Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Capa, Jorge Abad","Rosell, Antoni"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405161","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.rmed.2020.106023","keywords":["covid-19","d-dimer","pulmonary embolism"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666802845509222400,"score":188.56818},{"pmid":32454268,"title":"D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","text":["D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","OBJECTIVE: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. METHODS: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. RESULTS: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. CONCLUSION: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE.","Respir Med","Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Abad Capa, Jorge","Rosell, Antoni","32454268"],"abstract":["OBJECTIVE: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. METHODS: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. RESULTS: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. CONCLUSION: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE."],"journal":"Respir Med","authors":["Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Abad Capa, Jorge","Rosell, Antoni"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454268","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.rmed.2020.106023","keywords":["covid-19","d-dimer","pulmonary embolism"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667881798487506945,"score":188.56818},{"pmid":32374029,"title":"Arterial thromboembolic complications in COVID-19 in low risk patients despite prophylaxis.","text":["Arterial thromboembolic complications in COVID-19 in low risk patients despite prophylaxis.","We present a case series of three patients with COVID-19 who developed arterial vascular complications, one who developed an acute CVA, one who developed popliteal artery occlusion and one who developed both during their hospital course. We present a case series of three patients admitted to Northwell Plainview Hospital in Plainview, New York with COVID-19 as confirmed by PCR. The clinical disease course of COVID-19 has been well documented in China and Europe and most recently, the United States. Publications highlighting the non-respiratory complications of COVID-19 have been limited.[1, 2] Acute cardiac injury and arrhythmia in the ICU have been described as major complications of COVID-19.[3] A few publications have highlighted the incidence of venous thromboembolic complications in COVID-19.[4, 5].","Br J Haematol","Griffin, Daniel O","Jensen, Alexandra","Khan, Mushmoom","Chin, Jessica","Chin, Kelly","Parnell, Ryan","Awwad, Christopher","Patel, Darshan","32374029"],"abstract":["We present a case series of three patients with COVID-19 who developed arterial vascular complications, one who developed an acute CVA, one who developed popliteal artery occlusion and one who developed both during their hospital course. We present a case series of three patients admitted to Northwell Plainview Hospital in Plainview, New York with COVID-19 as confirmed by PCR. The clinical disease course of COVID-19 has been well documented in China and Europe and most recently, the United States. Publications highlighting the non-respiratory complications of COVID-19 have been limited.[1, 2] Acute cardiac injury and arrhythmia in the ICU have been described as major complications of COVID-19.[3] A few publications have highlighted the incidence of venous thromboembolic complications in COVID-19.[4, 5]."],"journal":"Br J Haematol","authors":["Griffin, Daniel O","Jensen, Alexandra","Khan, Mushmoom","Chin, Jessica","Chin, Kelly","Parnell, Ryan","Awwad, Christopher","Patel, Darshan"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32374029","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/bjh.16792","keywords":["covid-19","sars-cov2","hypercoagulability","pulmonary embolism","thromboembolic"],"locations":["Plainview","New York","China","United States"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138496393281540,"score":165.61243},{"pmid":32405101,"pmcid":"PMC7219400","title":"Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels.","text":["Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels.","Aim: An increased risk of venous thromboembolism (VTE) in patients with COVID-19 pneumonia admitted to intensive care unit (ICU) has been reported. Whether COVID-19 increases the risk of VTE in non-ICU wards remains unknown. We aimed to evaluate the burden of asymptomatic deep vein thrombosis (DVT) in COVID-19 patients with elevated D-dimer levels. Method: In this prospective study consecutive patients hospitalized in non-intensive care units with diagnosis of COVID-19 pneumonia and D-dimer>1000ng/mL were screened for asymptomatic DVT with complete compression doppler ultrasound (CCUS). The study was approved by the Institutional Ethics Committee. Results: The study comprised 156 patients (65.4% male). All but three patients received standard doses of thromboprophylaxis. Median days of hospitalization until CCUS was 9 (IQR 5-17). CCUS was positive for DVT in 23 patients (14.7%), of whom only one was proximal DVT. Seven patients (4.5%) had bilateral distal DVT. Patients with DVT had higher median D-dimer levels: 4527 (IQR 1925-9144) ng/ml vs 2050 (IQR 1428-3235) ng/ml; p<0.001. D-dimer levels>1570ng/mL were associated with asymptomatic DVT (OR 9.1; CI 95% 1.1-70.1). D-dimer showed an acceptable discriminative capacity (area under the ROC curve 0.72, 95% CI 0.61-0.84). Conclusion: In patients admitted with COVID-19 pneumonia and elevated D-dimer levels, the incidence of asymptomatic DVT is similar to that described in other series. Higher cut-off levels for D-dimer might be necessary for the diagnosis of DVT in COVID-19 patients.","Thromb Res","Demelo-Rodriguez, P","Cervilla-Munoz, E","Ordieres-Ortega, L","Parra-Virto, A","Toledano-Macias, M","Toledo-Samaniego, N","Garcia-Garcia, A","Garcia-Fernandez-Bravo, I","Ji, Z","de-Miguel-Diez, J","Alvarez-Sala-Walther, L A","Del-Toro-Cervera, J","Galeano-Valle, F","32405101"],"abstract":["Aim: An increased risk of venous thromboembolism (VTE) in patients with COVID-19 pneumonia admitted to intensive care unit (ICU) has been reported. Whether COVID-19 increases the risk of VTE in non-ICU wards remains unknown. We aimed to evaluate the burden of asymptomatic deep vein thrombosis (DVT) in COVID-19 patients with elevated D-dimer levels. Method: In this prospective study consecutive patients hospitalized in non-intensive care units with diagnosis of COVID-19 pneumonia and D-dimer>1000ng/mL were screened for asymptomatic DVT with complete compression doppler ultrasound (CCUS). The study was approved by the Institutional Ethics Committee. Results: The study comprised 156 patients (65.4% male). All but three patients received standard doses of thromboprophylaxis. Median days of hospitalization until CCUS was 9 (IQR 5-17). CCUS was positive for DVT in 23 patients (14.7%), of whom only one was proximal DVT. Seven patients (4.5%) had bilateral distal DVT. Patients with DVT had higher median D-dimer levels: 4527 (IQR 1925-9144) ng/ml vs 2050 (IQR 1428-3235) ng/ml; p<0.001. D-dimer levels>1570ng/mL were associated with asymptomatic DVT (OR 9.1; CI 95% 1.1-70.1). D-dimer showed an acceptable discriminative capacity (area under the ROC curve 0.72, 95% CI 0.61-0.84). Conclusion: In patients admitted with COVID-19 pneumonia and elevated D-dimer levels, the incidence of asymptomatic DVT is similar to that described in other series. Higher cut-off levels for D-dimer might be necessary for the diagnosis of DVT in COVID-19 patients."],"journal":"Thromb Res","authors":["Demelo-Rodriguez, P","Cervilla-Munoz, E","Ordieres-Ortega, L","Parra-Virto, A","Toledano-Macias, M","Toledo-Samaniego, N","Garcia-Garcia, A","Garcia-Fernandez-Bravo, I","Ji, Z","de-Miguel-Diez, J","Alvarez-Sala-Walther, L A","Del-Toro-Cervera, J","Galeano-Valle, F"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405101","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.thromres.2020.05.018","keywords":["covid-19","d-dimer","deep vein thrombosis","doppler ultrasound","sars-cov-2 infection","venous thromboembolism"],"locations":["thromboprophylaxis"],"topics":["Diagnosis"],"weight":1,"_version_":1666802845551165441,"score":148.72812},{"pmid":32473303,"title":"Inferior vena cava filter in a patient with COVID-19 pneumonia to prevent a massive pulmonary embolism.","text":["Inferior vena cava filter in a patient with COVID-19 pneumonia to prevent a massive pulmonary embolism.","COVID 19 predispose to deep vein thrombosis . We describe an early placement of inferior vena cava filter added to the therapeutic anticoagulation to prevent a massive pulmonary embolism.","Ann Vasc Surg","Cena, Tiziana","Bazzano, Simona","Berni, Paola","Vignazia, Gian Luca","Grossi, Francesca","Stanca, Carmelo","Cammarota, Gianmaria","Della Corte, Francesco","Vaschetto, Rosanna","32473303"],"abstract":["COVID 19 predispose to deep vein thrombosis . We describe an early placement of inferior vena cava filter added to the therapeutic anticoagulation to prevent a massive pulmonary embolism."],"journal":"Ann Vasc Surg","authors":["Cena, Tiziana","Bazzano, Simona","Berni, Paola","Vignazia, Gian Luca","Grossi, Francesca","Stanca, Carmelo","Cammarota, Gianmaria","Della Corte, Francesco","Vaschetto, Rosanna"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32473303","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.avsg.2020.05.032","keywords":["covid19","inferior vena cava filter","pulmonary embolism","anticoagulant therapy","deep vein thrombosis"],"topics":["Case Report"],"weight":1,"_version_":1668255193462996992,"score":147.4845}]}